Estimating the association between systemic Interleukin-6 and mortality in the dialysis population. Re-analysis of the global fluid study, systematic review and meta-analysis

被引:2
作者
Istanbuly, Obaida [1 ]
Belcher, John [1 ]
Tabinor, Matthew [1 ]
Solis-Trapala, Ivonne [1 ]
Lambie, Mark [1 ]
Davies, Simon J. [1 ]
机构
[1] Keele Univ, Fac Med & Hlth Sci, Sch Med, Keele, Staffs, England
关键词
IL-6; Systemic inflammation; Prognosis; Hemodialysis; Peritoneal Dialysis; Mortality; C-REACTIVE PROTEIN; PREDICTS CARDIOVASCULAR EVENTS; CHRONIC KIDNEY-DISEASE; CARDIAC TROPONIN-T; PERITONEAL-DIALYSIS; HEMODIALYSIS-PATIENTS; NUTRITIONAL-STATUS; INFLAMMATION; SURVIVAL; MALNUTRITION;
D O I
10.1186/s12882-023-03370-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Systemic inflammation, measured as circulating Interleukin-6 (IL-6) levels, is associated with cardiovascular and all-cause mortality in chronic kidney disease. However, this has not been convincingly demonstrated in a systematic review or a meta-analysis in the dialysis population. We provide such evidence, including a re-analysis of the GLOBAL Fluid Study. Methods Mortality in the GLOBAL fluid study was re-analysed using Cox proportional hazards regression with IL-6 levels as a covariate using a continuous non-logarithmic scale. Literature searches of the association of IL-6 levels with mortality were conducted on MEDLINE, EMBASE, PyschINFO and CENTRAL. All studies were assessed for risk of bias using the QUIPS tool. To calculate a pooled effect size, studies were grouped by use of IL-6 scale and included in the meta-analysis if IL-6 was analysed as a continuous linear covariate, either per unit or per 10 pg/ml, in both unadjusted or adjusted for other patient characteristics (e.g. age, comorbidity) models. Funnel plot was used to identify potential publication bias. Results Of 1886 citations identified from the electronic search, 60 were included in the qualitative analyses, and 12 had sufficient information to proceed to meta-analysis after full paper screening. Random effects meta-analysis of 11 articles yielded a pooled hazard ratio (HR) per pg/ml of 1.03, (95% CI 1.01, 1.03), I-2= 81%. When the analysis was confined to seven articles reporting a non-adjusted HR the result was similar: 1.03, per pg/ml (95% CI: 1.03, 1.06), I-2 =92%. Most of the heterogeneity could be attributed to three of the included studies. Publication bias could not be determined due to the limited number of studies. Conclusion This systematic review confirms the adverse association between systemic IL-6 levels and survival in people treated with dialysis. The heterogeneity that we observed may reflect differences in study case mix.
引用
收藏
页数:12
相关论文
共 63 条
  • [41] Ogrizovic SS, 2009, CLIN NEPHROL, V71, P164
  • [42] Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1136/bmj.n160, 10.1016/j.ijsu.2021.105906]
  • [43] Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients
    Panichi, V
    Maggiore, U
    Taccola, D
    Migliori, M
    Rizza, GM
    Consani, C
    Bertini, A
    Sposini, S
    Perez-Garcia, R
    Rindi, P
    Palla, R
    Tetta, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) : 1154 - 1160
  • [44] Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study
    Panichi, Vincenzo
    Rizza, Giovanni M.
    Paoletti, Sabrina
    Bigazzi, Roberto
    Aloisi, Mauro
    Barsotti, Giuliano
    Rindi, Paolo
    Donati, Giacli'
    Antonelli, Alessandro
    Panicucci, Erica
    Tripepi, Gianni
    Tetta, Ciro
    Palla, Roberto
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) : 2337 - 2343
  • [45] Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study
    Panichi, Vincenzo
    Rosati, Alberto
    Bigazzi, Roberto
    Paoletti, Sabrina
    Mantuano, Emanuela
    Beati, Sara
    Marchetti, Valentina
    Bernabini, Giada
    Grazi, Giovanni
    Rizza, Giovanni Manca
    Migliori, Massimiliano
    Giusti, Riccardo
    Lippi, Alberto
    Casani, Aldo
    Barsotti, Giuliano
    Tetta, Ciro
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (08) : 2641 - U1808
  • [46] Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment
    Pecoits-Filho, R
    Bárány, P
    Lindholm, B
    Heimbürger, O
    Stenvinkel, P
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (09) : 1684 - 1688
  • [47] Serum levels of anti-αGalactosyl antibodies predict survival and peritoneal dialysis -: Related enteric peritonitis rates in patients undergoing renal replacement therapy
    Perez Fontan, Miguel
    Manez, Rafael
    Rodriguez-Carmona, Ana
    Peteiro, Javier
    Martinez, Veronica
    Garcia-Falcon, Teresa
    Domenech, Nieves
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (06) : 972 - 982
  • [48] Malnutrition inflammation score (MIS) is stronger predictor of mortality in hemodialysis patients than waist-to-hip ratio (WHR)-4-year follow-up
    Prelevic, Vladimir
    Antunovic, Tanja
    Radunovic, Danilo
    Gligorovic-Barhanovic, Najdana
    Gledovic, Branka
    Ratkovic, Marina
    Jukic, Nikolina Basic
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (03) : 695 - 700
  • [49] Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients
    Rao, M
    Guo, DQ
    Perianayagam, MC
    Tighiouart, H
    Jaber, BL
    Pereira, BJG
    Balakrishnan, VS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) : 324 - 333
  • [50] Plasma adiponectin levels and clinical outcomes among haemodialysis patients
    Rao, Madhumathi
    Li, Lijun
    Tighiouart, Hocine
    Jaber, Bertrand L.
    Pereira, Brian J. G.
    Balakrishnan, Vaidyanathapuram S.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (08) : 2619 - 2628